Catalyst Wire Dossier Catalyst Wire Dossier

Hepatitis B therapeutic vaccine candidate (heterologous protein prime/MVA boost)

· Universitätsklinikum Hamburg-Eppendorf
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Hepatitis B therapeutic vaccine candidate (heterologous protein prime/MVA boost), covering 2025-04-24 to 2025-04-24. Get the full timeline:

Most recent: Clinical Trial Update: A Heterologous Protein Prime/MVA Boost Therapeutic Hepatitis B Vaccine Candidate [Phase 1]

See pricing